首页 > 最新文献

Pediatric quality & safety最新文献

英文 中文
Improving Antibiotic Use in Argentine Pediatric Hospitals: A Process Evaluation Using Normalization Process Theory. 改善阿根廷儿科医院抗生素使用:使用规范化过程理论的过程评价。
IF 1.2 Q3 PEDIATRICS Pub Date : 2025-01-07 eCollection Date: 2025-01-01 DOI: 10.1097/pq9.0000000000000788
Javier Roberti, Facundo Jorro-Barón, Natalí Ini, Marina Guglielmino, Ana Paula Rodríguez, Cecilia Echave, Andrea Falaschi, Viviana E Rodríguez, Ezequiel García-Elorrio, Juan Pedro Alonso

Introduction: In the pediatric setting, overprescribing of antibiotics contributes to the rise of multidrug-resistant organisms. Antimicrobial stewardship programs (ASPs) are recommended to optimize antibiotic use and combat resistance. However, the implementation of ASPs in low- and middle-income countries faces several challenges. This study aimed to evaluate the implementation process of a multifaceted ASP in 2 pediatric hospitals in Argentina.

Methods: A qualitative study was conducted in two large public children's hospitals in Argentina, using semistructured interviews with 32 healthcare providers at the beginning and end of the ASP implementation. The study was guided by the normalization process theory.

Results: The intervention faced challenges, including limited understanding of its objectives, confusion with existing practices, and insufficient commitment from senior staff. Although junior staff were more receptive, communication barriers with external staff and workload concerns hindered broader adoption. Infectious disease specialists primarily led implementation, with limited involvement of other staff, particularly in training activities. Despite these challenges, participants reported improvements, such as the development of standardized antibiotic guidelines, better interdisciplinary collaboration, and improved communication. However, organizational support and resistance to new practices remained barriers.

Conclusions: This study highlights the importance of organizational context and staff commitment in ASP implementation. Tailored strategies that address the specific challenges of low- and middle-income countries are needed to effectively implement ASPs.

在儿科环境中,抗生素的过量使用导致了多重耐药菌的增加。抗菌素管理计划(asp)建议优化抗生素使用和对抗耐药性。然而,在低收入和中等收入国家实施应用标准方案面临若干挑战。本研究旨在评估阿根廷两家儿科医院实施多方面ASP的过程。方法:在阿根廷的两家大型公立儿童医院进行了一项定性研究,在ASP实施的开始和结束时对32名医疗保健提供者进行了半结构化访谈。本研究以归一化过程理论为指导。结果:干预面临挑战,包括对其目标的理解有限,与现有实践的混淆,以及高级人员的承诺不足。虽然初级工作人员更容易接受,但与外部工作人员的沟通障碍和工作量问题阻碍了广泛采用。传染病专家主要领导实施工作,其他工作人员的参与有限,特别是在培训活动方面。尽管存在这些挑战,但与会者报告了一些进展,例如制定了标准化的抗生素指南、更好的跨学科合作和改进的沟通。然而,组织对新实践的支持和抵制仍然是障碍。结论:本研究强调了组织背景和员工承诺在ASP实施中的重要性。需要针对低收入和中等收入国家的具体挑战制定量身定制的战略,以有效实施应用标准方案。
{"title":"Improving Antibiotic Use in Argentine Pediatric Hospitals: A Process Evaluation Using Normalization Process Theory.","authors":"Javier Roberti, Facundo Jorro-Barón, Natalí Ini, Marina Guglielmino, Ana Paula Rodríguez, Cecilia Echave, Andrea Falaschi, Viviana E Rodríguez, Ezequiel García-Elorrio, Juan Pedro Alonso","doi":"10.1097/pq9.0000000000000788","DOIUrl":"https://doi.org/10.1097/pq9.0000000000000788","url":null,"abstract":"<p><strong>Introduction: </strong>In the pediatric setting, overprescribing of antibiotics contributes to the rise of multidrug-resistant organisms. Antimicrobial stewardship programs (ASPs) are recommended to optimize antibiotic use and combat resistance. However, the implementation of ASPs in low- and middle-income countries faces several challenges. This study aimed to evaluate the implementation process of a multifaceted ASP in 2 pediatric hospitals in Argentina.</p><p><strong>Methods: </strong>A qualitative study was conducted in two large public children's hospitals in Argentina, using semistructured interviews with 32 healthcare providers at the beginning and end of the ASP implementation. The study was guided by the normalization process theory.</p><p><strong>Results: </strong>The intervention faced challenges, including limited understanding of its objectives, confusion with existing practices, and insufficient commitment from senior staff. Although junior staff were more receptive, communication barriers with external staff and workload concerns hindered broader adoption. Infectious disease specialists primarily led implementation, with limited involvement of other staff, particularly in training activities. Despite these challenges, participants reported improvements, such as the development of standardized antibiotic guidelines, better interdisciplinary collaboration, and improved communication. However, organizational support and resistance to new practices remained barriers.</p><p><strong>Conclusions: </strong>This study highlights the importance of organizational context and staff commitment in ASP implementation. Tailored strategies that address the specific challenges of low- and middle-income countries are needed to effectively implement ASPs.</p>","PeriodicalId":74412,"journal":{"name":"Pediatric quality & safety","volume":"10 1","pages":"e788"},"PeriodicalIF":1.2,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703432/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transitioning to Opioid-free Anesthesia for Pediatric Supracondylar Fracture Repairs: A Patient Safety Report. 过渡到无阿片类药物麻醉用于儿童髁上骨折修复:患者安全报告。
IF 1.2 Q3 PEDIATRICS Pub Date : 2025-01-07 eCollection Date: 2025-01-01 DOI: 10.1097/pq9.0000000000000777
Laurence O Henson, Jennifer Chiem, Emmanuella Joseph, Fiona Patrao, Daniel King-Wai Low

Introduction: Supracondylar fractures are among the most common injuries in the pediatric population. Recently, there has been increased interest in developing opioid-free anesthetic protocols that achieve these same goals without the risks associated with opioid use, such as postoperative nausea and vomiting (PONV), delayed discharges, and respiratory depression.

Methods: Seattle Children's Hospital implemented opioid-free anesthesia (OFA) for pediatric supracondylar fracture repairs in January 2021. This patient safety report compares the clinical outcomes of these patients to those who received intraoperative opioids. Clinical effectiveness was measured using the maximum pain scores in the postanesthesia care unit (PACU), postoperative opioid rescue rates in PACU and PONV rescue rate. PACU length of stay (LOS) was chosen as a clinical balancing measure.

Results: The opioid group (n = 464) had a mean maximum pain score of 3.39 compared with the OFA group (n = 816), which had a mean maximum of 3.70. The PACU IV opioid rescue rate for the opioid group was 38.82%, whereas the OFA group was 38.73%. The opioid group had a PONV rescue rate of 1.53%, compared with 0.23% in the OFA group. Mean LOS in the PACU was 79 minutes for the opioid group and 86 minutes for the OFA group.

Conclusions: The shift to OFA for intraoperative management of patients' supracondylar fracture repair resulted in similar postoperative analgesic outcomes when compared with an opioid-based approach, with a reduced PONV rate and minimal increase in LOS. Transitioning to OFA provided a safe and effective protocol for supracondylar repairs.

简介:髁上骨折是儿科人群中最常见的损伤之一。最近,人们对开发无阿片类药物麻醉方案越来越感兴趣,这些方案可以实现相同的目标,而不会产生与阿片类药物使用相关的风险,如术后恶心和呕吐(PONV)、延迟出院和呼吸抑制。方法:西雅图儿童医院于2021年1月实施无阿片类麻醉(OFA)用于儿童髁上骨折修复。本患者安全报告比较了这些患者与术中使用阿片类药物的患者的临床结果。采用麻醉后护理单元(PACU)的最大疼痛评分、PACU的术后阿片类药物抢救率和PONV抢救率来衡量临床疗效。选择PACU住院时间(LOS)作为临床平衡指标。结果:阿片类药物组(n = 464)的平均最大疼痛评分为3.39,OFA组(n = 816)的平均最大疼痛评分为3.70。阿片类药物组PACU IV阿片类药物抢救率为38.82%,OFA组为38.73%。阿片类药物组PONV抢救率为1.53%,OFA组为0.23%。阿片类药物组PACU的平均LOS为79分钟,OFA组为86分钟。结论:与基于阿片类药物的入路相比,术中使用OFA治疗髁上骨折患者的术后镇痛效果相似,PONV率降低,LOS增加最小。过渡到OFA为髁上修复提供了安全有效的方案。
{"title":"Transitioning to Opioid-free Anesthesia for Pediatric Supracondylar Fracture Repairs: A Patient Safety Report.","authors":"Laurence O Henson, Jennifer Chiem, Emmanuella Joseph, Fiona Patrao, Daniel King-Wai Low","doi":"10.1097/pq9.0000000000000777","DOIUrl":"https://doi.org/10.1097/pq9.0000000000000777","url":null,"abstract":"<p><strong>Introduction: </strong>Supracondylar fractures are among the most common injuries in the pediatric population. Recently, there has been increased interest in developing opioid-free anesthetic protocols that achieve these same goals without the risks associated with opioid use, such as postoperative nausea and vomiting (PONV), delayed discharges, and respiratory depression.</p><p><strong>Methods: </strong>Seattle Children's Hospital implemented opioid-free anesthesia (OFA) for pediatric supracondylar fracture repairs in January 2021. This patient safety report compares the clinical outcomes of these patients to those who received intraoperative opioids. Clinical effectiveness was measured using the maximum pain scores in the postanesthesia care unit (PACU), postoperative opioid rescue rates in PACU and PONV rescue rate. PACU length of stay (LOS) was chosen as a clinical balancing measure.</p><p><strong>Results: </strong>The opioid group (n = 464) had a mean maximum pain score of 3.39 compared with the OFA group (n = 816), which had a mean maximum of 3.70. The PACU IV opioid rescue rate for the opioid group was 38.82%, whereas the OFA group was 38.73%. The opioid group had a PONV rescue rate of 1.53%, compared with 0.23% in the OFA group. Mean LOS in the PACU was 79 minutes for the opioid group and 86 minutes for the OFA group.</p><p><strong>Conclusions: </strong>The shift to OFA for intraoperative management of patients' supracondylar fracture repair resulted in similar postoperative analgesic outcomes when compared with an opioid-based approach, with a reduced PONV rate and minimal increase in LOS. Transitioning to OFA provided a safe and effective protocol for supracondylar repairs.</p>","PeriodicalId":74412,"journal":{"name":"Pediatric quality & safety","volume":"10 1","pages":"e777"},"PeriodicalIF":1.2,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703429/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142960090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lessons Learned from a Quality Improvement Initiative to Increase COVID-19 Vaccination in Hospitalized Children. 提高住院儿童COVID-19疫苗接种质量改进倡议的经验教训。
IF 1.2 Q3 PEDIATRICS Pub Date : 2025-01-07 eCollection Date: 2025-01-01 DOI: 10.1097/pq9.0000000000000782
Daniel G Young, Cortney S Rogers, Isaac Mayefsky, Thomas Neufeld, Angela Niesen, Patrick J Reich, Carol M Kao, Mythili Srinivasan

Introduction: Pediatric coronavirus disease 2019 (COVID-19) vaccination rates in the United States remain lower compared with adults. We aimed to (1) implement a quality improvement initiative to increase COVID-19 vaccination 2-fold in hospitalized patients 12-21 years of age from 4.7% during the baseline period (August 10, 2021-November 1, 2021) to 9.4% during the intervention phase (November 2, 2021-March 31, 2023) and (2) assess the importance of existing interventions and obtain feedback for future interventions to increase COVID-19 vaccination via a provider survey.

Methods: We conducted the quality improvement initiative in the inpatient units of a freestanding children's hospital. Interventions included provider education, electronic medical record best practice alerts, monthly competition, parental counseling to increase vaccine acceptance, and ensuring vaccine availability. The primary outcome measure was the percentage of hospitalized patients 12-21 years of age who received COVID-19 vaccine. Providers addressing COVID-19 vaccination with patients, as documented by COVID-19-specific problem lists, were a process measure. Length of stay was a balancing measure.

Results: Although COVID-19 vaccination increased 1.6-fold during the initial 5 months of interventions, the interrupted time series analysis did not show a significant impact of our interventions on vaccination. Documentation of COVID-19 vaccine-specific problem lists increased 1.9-fold during most of the intervention period. There was no significant (P = 0.61) difference in length of stay between children in the baseline and intervention groups.

Conclusions: Despite our best efforts, we could not increase the number of COVID-19 vaccinations in our patients. Lessons learned suggest that creating a nurse-driven COVID-19 vaccine screening/ordering protocol and integrating COVID-19/influenza vaccination annually during influenza season can potentially increase vaccination rates, but further research is required.

美国儿童2019冠状病毒病(COVID-19)疫苗接种率仍低于成人。我们的目标是(1)实施一项质量改进计划,将12-21岁住院患者的COVID-19疫苗接种率提高2倍,从基线期(2021年8月10日- 2021年11月1日)的4.7%提高到干预阶段(2021年11月2日- 2023年3月31日)的9.4%。(2)评估现有干预措施的重要性,并通过一项提供者调查获得未来干预措施的反馈,以增加COVID-19疫苗接种率。方法:对某独立儿童医院住院单元进行质量改进。干预措施包括提供者教育、电子病历最佳做法警报、每月竞赛、家长咨询以提高疫苗接受度,并确保疫苗供应。主要结局指标是12-21岁住院患者接种COVID-19疫苗的百分比。根据COVID-19特定问题清单所记录的,为患者提供COVID-19疫苗接种的提供者是一项过程措施。停留时间长短是一种平衡措施。结果:尽管在干预的最初5个月内COVID-19疫苗接种增加了1.6倍,但中断时间序列分析并未显示干预对疫苗接种的显着影响。在大部分干预期间,COVID-19疫苗特异性问题清单的记录增加了1.9倍。基线组和干预组儿童的住院时间差异无统计学意义(P = 0.61)。结论:尽管我们尽了最大努力,但我们无法增加患者的COVID-19疫苗接种次数。经验教训表明,制定由护士主导的COVID-19疫苗筛查/订购方案,并在流感季节每年整合COVID-19/流感疫苗接种,可能会提高疫苗接种率,但需要进一步研究。
{"title":"Lessons Learned from a Quality Improvement Initiative to Increase COVID-19 Vaccination in Hospitalized Children.","authors":"Daniel G Young, Cortney S Rogers, Isaac Mayefsky, Thomas Neufeld, Angela Niesen, Patrick J Reich, Carol M Kao, Mythili Srinivasan","doi":"10.1097/pq9.0000000000000782","DOIUrl":"https://doi.org/10.1097/pq9.0000000000000782","url":null,"abstract":"<p><strong>Introduction: </strong>Pediatric coronavirus disease 2019 (COVID-19) vaccination rates in the United States remain lower compared with adults. We aimed to (1) implement a quality improvement initiative to increase COVID-19 vaccination 2-fold in hospitalized patients 12-21 years of age from 4.7% during the baseline period (August 10, 2021-November 1, 2021) to 9.4% during the intervention phase (November 2, 2021-March 31, 2023) and (2) assess the importance of existing interventions and obtain feedback for future interventions to increase COVID-19 vaccination via a provider survey.</p><p><strong>Methods: </strong>We conducted the quality improvement initiative in the inpatient units of a freestanding children's hospital. Interventions included provider education, electronic medical record best practice alerts, monthly competition, parental counseling to increase vaccine acceptance, and ensuring vaccine availability. The primary outcome measure was the percentage of hospitalized patients 12-21 years of age who received COVID-19 vaccine. Providers addressing COVID-19 vaccination with patients, as documented by COVID-19-specific problem lists, were a process measure. Length of stay was a balancing measure.</p><p><strong>Results: </strong>Although COVID-19 vaccination increased 1.6-fold during the initial 5 months of interventions, the interrupted time series analysis did not show a significant impact of our interventions on vaccination. Documentation of COVID-19 vaccine-specific problem lists increased 1.9-fold during most of the intervention period. There was no significant (<i>P</i> = 0.61) difference in length of stay between children in the baseline and intervention groups.</p><p><strong>Conclusions: </strong>Despite our best efforts, we could not increase the number of COVID-19 vaccinations in our patients. Lessons learned suggest that creating a nurse-driven COVID-19 vaccine screening/ordering protocol and integrating COVID-19/influenza vaccination annually during influenza season can potentially increase vaccination rates, but further research is required.</p>","PeriodicalId":74412,"journal":{"name":"Pediatric quality & safety","volume":"10 1","pages":"e782"},"PeriodicalIF":1.2,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703428/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142960044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Standardized Approach to Transition Improves Care of Young Adults with Inflammatory Bowel Disease. 一种标准化的过渡方法改善了患有炎症性肠病的年轻人的护理。
IF 1.2 Q3 PEDIATRICS Pub Date : 2025-01-07 eCollection Date: 2025-01-01 DOI: 10.1097/pq9.0000000000000786
Daphna Katz, Stephanie Lee, Vidiya Sathananthan, Liz Bayes Santos, Amber Langshaw

Introduction: Young adults with inflammatory bowel disease (IBD) are at the risk of poor outcomes when transferring to adult providers. We aimed to increase the percentage of patients with 14-17 years of age undergoing the transition of care and the percentage of patients 18-21 years of age initiating the transfer of care to 50% for 12 months. Our goal was also to improve patient satisfaction with the transfer process. Our balancing measure was not to increase the duration of IBD visits.

Methods: We implemented 3 interventions through iterative plan-do-study-act cycles. To understand the impact of the interventions for 12 months, we used statistical process control charts. The duration of IBD visits was used as a balancing measure. We administered an anonymous satisfaction survey through the electronic health record.

Results: Total transition discussions increased to a mean of 38% (n = 68). Transition discussions with patients 14-17 years of age increased from baseline, though not consistently. Patients 18-21 years of age initiating transfer of care increased to a mean of 5% (n = 1) following the first intervention and to a mean of 30% (n = 13) following our second and third interventions with special cause variation. There was no significant difference in the duration of IBD visits before and after the intervention period (P = 0.54). No patients were dissatisfied following our interventions.

Conclusions: We saw improved transition discussions and transfer initiation rates by implementing the first steps of a new process to transition young adults with IBD.

患有炎症性肠病(IBD)的年轻成人在转诊给成人医生时面临预后不良的风险。我们的目标是在12个月的时间里,将14-17岁的患者接受转移治疗的比例和18-21岁的患者开始转移治疗的比例提高到50%。我们的目标也是提高患者对转移过程的满意度。我们的平衡措施是不增加IBD就诊的持续时间。方法:通过计划-实施-研究-实施循环,实施3项干预措施。为了了解12个月的干预措施的影响,我们使用了统计过程控制图。IBD访问的持续时间被用作一种平衡措施。我们通过电子健康记录进行了一次匿名满意度调查。结果:总转移讨论增加到平均38% (n = 68)。与14-17岁患者的过渡讨论从基线开始增加,尽管不一致。在第一次干预后,18-21岁的患者开始转移护理的平均比例增加到5% (n = 1),在我们的第二次和第三次特殊原因变化干预后,平均比例增加到30% (n = 13)。干预前后IBD就诊时间差异无统计学意义(P = 0.54)。没有患者对我们的干预不满意。结论:我们看到,通过实施一个新过程的第一步,年轻人IBD的转移讨论和转移起始率得到了改善。
{"title":"A Standardized Approach to Transition Improves Care of Young Adults with Inflammatory Bowel Disease.","authors":"Daphna Katz, Stephanie Lee, Vidiya Sathananthan, Liz Bayes Santos, Amber Langshaw","doi":"10.1097/pq9.0000000000000786","DOIUrl":"https://doi.org/10.1097/pq9.0000000000000786","url":null,"abstract":"<p><strong>Introduction: </strong>Young adults with inflammatory bowel disease (IBD) are at the risk of poor outcomes when transferring to adult providers. We aimed to increase the percentage of patients with 14-17 years of age undergoing the transition of care and the percentage of patients 18-21 years of age initiating the transfer of care to 50% for 12 months. Our goal was also to improve patient satisfaction with the transfer process. Our balancing measure was not to increase the duration of IBD visits.</p><p><strong>Methods: </strong>We implemented 3 interventions through iterative plan-do-study-act cycles. To understand the impact of the interventions for 12 months, we used statistical process control charts. The duration of IBD visits was used as a balancing measure. We administered an anonymous satisfaction survey through the electronic health record.</p><p><strong>Results: </strong>Total transition discussions increased to a mean of 38% (n = 68). Transition discussions with patients 14-17 years of age increased from baseline, though not consistently. Patients 18-21 years of age initiating transfer of care increased to a mean of 5% (n = 1) following the first intervention and to a mean of 30% (n = 13) following our second and third interventions with special cause variation. There was no significant difference in the duration of IBD visits before and after the intervention period (<i>P</i> = 0.54). No patients were dissatisfied following our interventions.</p><p><strong>Conclusions: </strong>We saw improved transition discussions and transfer initiation rates by implementing the first steps of a new process to transition young adults with IBD.</p>","PeriodicalId":74412,"journal":{"name":"Pediatric quality & safety","volume":"10 1","pages":"e786"},"PeriodicalIF":1.2,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11703434/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142960033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improved Adherence to Lipid Screening in the Pediatric Cardiology Clinic: A Quality Improvement Project. 提高依从性脂质筛查在儿科心脏病诊所:质量改进项目。
IF 1.2 Q3 PEDIATRICS Pub Date : 2024-12-24 eCollection Date: 2025-01-01 DOI: 10.1097/pq9.0000000000000781
Rachel A Magnan, Thomas Murphy, Lauren Rosenthal, Aparna Prasad, Anjali Chelliah, Stuart Kaufman, Donna Timchak, Lindsey McPhillips, Saira Siddiqui

Introduction: Lipid screening identifies at-risk patients to facilitate cardiovascular risk reduction. National pediatric guidelines recommend universal lipid screening between 9-11 and 17-21 years of age. We aimed to improve adherence to lipid screening for all age-appropriate outpatient pediatric cardiology visits from a baseline of 35% to 90% between November 2021 and July 2023.

Methods: All outpatient visits for patients 9-11 and 17-21 years were included. Chart review and an Epic electronic health record report identified patients screened, lipid test results, and need for further testing. A P-chart was generated. After establishing a baseline for 8 weeks, interventions, including an Epic dot phrase, group and individual feedback, and Epic best practice alert (BPA), were incorporated via plan-do-study-act cycles. Balancing measures included anonymous provider surveys on visit length and experience.

Results: More than 1,700 patient visits were included. At baseline, 35% of all age-appropriate patients were screened. The Epic dot phrase prompted a positive shift with a new mean of 59% screened. Another change occurred after the BPA alert, with an increase in screening to 84%. Lipid screening prompted by this initiative found that 38% of those with testing results in Epic had abnormal results requiring follow-up. Providers did not report a significant change in visit length due to screening.

Conclusions: Quality improvement interventions improved adherence to universal lipid screening guidelines. The Epic dot phrase and BPA facilitated positive shifts. These simple interventions can be spread to other practices to improve adherence to lipid screening and other guidelines.

简介:脂质筛查识别高危患者,促进心血管风险降低。国家儿科指南建议在9-11岁和17-21岁之间进行普遍的脂质筛查。我们的目标是在2021年11月至2023年7月期间,将所有与年龄相适应的儿科心脏病门诊就诊的脂质筛查依从性从基线的35%提高到90%。方法:收集9-11岁和17-21岁患者的门诊资料。图表审查和Epic电子健康记录报告确定了筛选的患者、脂质测试结果以及是否需要进一步测试。生成了p图。在建立基线8周后,通过计划-执行-研究-行动循环纳入干预措施,包括Epic点式短语、团体和个人反馈以及Epic最佳实践警报(BPA)。平衡措施包括匿名提供者对访问时长和体验的调查。结果:纳入了1700多例患者就诊。在基线时,35%的适龄患者接受了筛查。Epic点号短语带来了积极的转变,新平均值达到59%。另一个变化发生在BPA警报之后,筛查率增加到84%。这一举措引发的脂质筛查发现,38%的Epic检测结果异常,需要随访。提供者没有报告由于筛查而导致就诊时间的显著变化。结论:质量改善干预措施提高了对通用脂质筛查指南的依从性。史诗点短语和BPA促进了积极的转变。这些简单的干预措施可以推广到其他实践中,以提高对脂质筛查和其他指导方针的依从性。
{"title":"Improved Adherence to Lipid Screening in the Pediatric Cardiology Clinic: A Quality Improvement Project.","authors":"Rachel A Magnan, Thomas Murphy, Lauren Rosenthal, Aparna Prasad, Anjali Chelliah, Stuart Kaufman, Donna Timchak, Lindsey McPhillips, Saira Siddiqui","doi":"10.1097/pq9.0000000000000781","DOIUrl":"10.1097/pq9.0000000000000781","url":null,"abstract":"<p><strong>Introduction: </strong>Lipid screening identifies at-risk patients to facilitate cardiovascular risk reduction. National pediatric guidelines recommend universal lipid screening between 9-11 and 17-21 years of age. We aimed to improve adherence to lipid screening for all age-appropriate outpatient pediatric cardiology visits from a baseline of 35% to 90% between November 2021 and July 2023.</p><p><strong>Methods: </strong>All outpatient visits for patients 9-11 and 17-21 years were included. Chart review and an Epic electronic health record report identified patients screened, lipid test results, and need for further testing. A P-chart was generated. After establishing a baseline for 8 weeks, interventions, including an Epic dot phrase, group and individual feedback, and Epic best practice alert (BPA), were incorporated via plan-do-study-act cycles. Balancing measures included anonymous provider surveys on visit length and experience.</p><p><strong>Results: </strong>More than 1,700 patient visits were included. At baseline, 35% of all age-appropriate patients were screened. The Epic dot phrase prompted a positive shift with a new mean of 59% screened. Another change occurred after the BPA alert, with an increase in screening to 84%. Lipid screening prompted by this initiative found that 38% of those with testing results in Epic had abnormal results requiring follow-up. Providers did not report a significant change in visit length due to screening.</p><p><strong>Conclusions: </strong>Quality improvement interventions improved adherence to universal lipid screening guidelines. The Epic dot phrase and BPA facilitated positive shifts. These simple interventions can be spread to other practices to improve adherence to lipid screening and other guidelines.</p>","PeriodicalId":74412,"journal":{"name":"Pediatric quality & safety","volume":"10 1","pages":"e781"},"PeriodicalIF":1.2,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11671070/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142904366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reducing Sedation for Pediatric Thoracic CT Imaging Using Volumetric Target-mode EKG Gating. 使用体积靶型心电图门控减少镇静对儿童胸部CT成像的影响。
IF 1.2 Q3 PEDIATRICS Pub Date : 2024-12-24 eCollection Date: 2025-01-01 DOI: 10.1097/pq9.0000000000000779
Summit H Shah, Cody M Young, Jessica Morrison, Margarita Chmil, Lynne Ruess, Rajesh Krishnamurthy

Introduction: Many children require sedation for imaging. We aimed to reduce sedation for thoracic (chest and cardiac) computed tomography (CT) scans in children 0-4 years old from 65% to 20% by December 2018 and to sustain.

Methods: We counted baseline, intervention, and a follow-up period thoracic CT scans performed with sedation in children 0-4 years old. We developed a new volumetric target-mode electrocardiogram-gated CT imaging protocol to reduce scan time and control for factors that decrease image quality. Additional interventions included technologist training, communication to radiologists and clinicians, and eliminating a default request for sedation accompanying the electronic order for most thoracic CT scans. A statistical process control chart tracked data to study process changes over time.

Results: During the baseline and intervention periods, 232 of 357 and 217 of 794 scans required sedation. Interventions created 2 centerline shifts. Overall, thoracic CT scans in children 0-4 years old requiring sedation decreased from 65% to 24% and was sustained 5 years later. No patients during the baseline period, one (1 of 794, 0.1%) during the intervention period and 2 (2 of 480, 0.4%) during the audit period 5 years later, initially had nondiagnostic nonsedated scans that required an additional scan with sedation.

Conclusions: We developed a volumetric target-mode electrocardiogram-gated CT protocol, eliminated default sedation ordering, and trained and educated staff to reduce sedation in young children undergoing thoracic CT scans. The frequency of sedation for thoracic CT in children 0-4 years old decreased from 65% to 24% and was sustained after revising imaging parameters and eliminating a default sedation order.

许多儿童需要镇静成像。我们的目标是到2018年12月将0-4岁儿童胸部(胸部和心脏)计算机断层扫描(CT)的镇静率从65%降低到20%,并维持下去。方法:我们统计了0-4岁儿童在镇静下进行的基线、干预和随访期间的胸部CT扫描。我们开发了一种新的体积靶型心电图门控CT成像方案,以减少扫描时间并控制降低图像质量的因素。其他干预措施包括技术人员培训,与放射科医生和临床医生沟通,以及消除大多数胸部CT扫描电子订单附带的默认镇静请求。统计过程控制图跟踪数据以研究过程随时间的变化。结果:在基线和干预期间,357次扫描中有232次需要镇静,794次扫描中有217次需要镇静。干预产生了2个中心线转变。总体而言,需要镇静的0-4岁儿童的胸部CT扫描从65%下降到24%,并在5年后持续。在基线期间,1例(794例中有1例,占0.1%)在干预期间,2例(480例中有2例,占0.4%)在5年后的审计期间,没有患者最初进行非诊断性非镇静扫描,需要在镇静下进行额外扫描。结论:我们开发了一种容积靶型心电图门控CT方案,取消了默认的镇静顺序,并对接受胸部CT扫描的幼儿进行了培训和教育,以减少镇静。0-4岁儿童胸部CT的镇静频率从65%下降到24%,并在修改成像参数和取消默认镇静顺序后得以维持。
{"title":"Reducing Sedation for Pediatric Thoracic CT Imaging Using Volumetric Target-mode EKG Gating.","authors":"Summit H Shah, Cody M Young, Jessica Morrison, Margarita Chmil, Lynne Ruess, Rajesh Krishnamurthy","doi":"10.1097/pq9.0000000000000779","DOIUrl":"10.1097/pq9.0000000000000779","url":null,"abstract":"<p><strong>Introduction: </strong>Many children require sedation for imaging. We aimed to reduce sedation for thoracic (chest and cardiac) computed tomography (CT) scans in children 0-4 years old from 65% to 20% by December 2018 and to sustain.</p><p><strong>Methods: </strong>We counted baseline, intervention, and a follow-up period thoracic CT scans performed with sedation in children 0-4 years old. We developed a new volumetric target-mode electrocardiogram-gated CT imaging protocol to reduce scan time and control for factors that decrease image quality. Additional interventions included technologist training, communication to radiologists and clinicians, and eliminating a default request for sedation accompanying the electronic order for most thoracic CT scans. A statistical process control chart tracked data to study process changes over time.</p><p><strong>Results: </strong>During the baseline and intervention periods, 232 of 357 and 217 of 794 scans required sedation. Interventions created 2 centerline shifts. Overall, thoracic CT scans in children 0-4 years old requiring sedation decreased from 65% to 24% and was sustained 5 years later. No patients during the baseline period, one (1 of 794, 0.1%) during the intervention period and 2 (2 of 480, 0.4%) during the audit period 5 years later, initially had nondiagnostic nonsedated scans that required an additional scan with sedation.</p><p><strong>Conclusions: </strong>We developed a volumetric target-mode electrocardiogram-gated CT protocol, eliminated default sedation ordering, and trained and educated staff to reduce sedation in young children undergoing thoracic CT scans. The frequency of sedation for thoracic CT in children 0-4 years old decreased from 65% to 24% and was sustained after revising imaging parameters and eliminating a default sedation order.</p>","PeriodicalId":74412,"journal":{"name":"Pediatric quality & safety","volume":"10 1","pages":"e779"},"PeriodicalIF":1.2,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11671082/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142904373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reducing Intubations and Related Risks in Neonates with Retinopathy of Prematurity Undergoing Laser Photocoagulation. 激光光凝治疗早产儿视网膜病变减少插管及相关风险。
IF 1.2 Q3 PEDIATRICS Pub Date : 2024-12-24 eCollection Date: 2025-01-01 DOI: 10.1097/pq9.0000000000000780
Vilmaris Quinones Cardona, Emma McNell Byrne, Novisi Arthur, Megan Young, Diane Lavery, Amanda Carroll, Swosti Joshi, Folasade Kehinde, Ogechukwu Menkiti

Introduction: Although associated with respiratory morbidity, elective endotracheal intubation (ETI) for laser photocoagulation for retinopathy of prematurity (ROP) is the standard practice at our institution, with 100% of patients undergoing preoperation ETI. To mitigate this risk, we strove to reduce the percentage of infants intubated for laser photocoagulation by 30% by June 2022.

Methods: We assembled a multidisciplinary team and implemented a deep sedation guideline utilizing dexmedetomidine, fentanyl, and midazolam with noninvasive ventilation support for laser photocoagulation in January 2020. Outcome, process, and balancing measures tracked the efficacy and safety of the quality improvement project.

Results: We reduced the percentage of infants requiring intubation for laser photocoagulation from 100% (8/8) to 10% (1/10). We reduced the average time to return to baseline respiratory status from 224.1 to 33.8 hours (9.3d to1.4 d). Cardiorespiratory index scores slightly increased (1 to 1.2), and pain scores remained unchanged after interventions.

Conclusions: A multidisciplinary team approach using a deep sedation guideline and noninvasive ventilation can safely reduce the requirement for intubation during laser photocoagulation with a faster return to baseline respiratory status.

虽然与呼吸系统疾病相关,但选择性气管内插管(ETI)用于激光光凝治疗早产儿视网膜病变(ROP)是我们机构的标准做法,100%的患者接受术前ETI。为了降低这种风险,我们努力在2022年6月之前将插管进行激光光凝治疗的婴儿比例降低30%。方法:我们组建了一个多学科团队,并于2020年1月实施了使用右美托咪定、芬太尼和咪达唑仑在无创通气支持下进行激光光凝的深度镇静指南。结果、过程和平衡度量跟踪质量改进项目的有效性和安全性。结果:我们将需要插管进行激光光凝的婴儿比例从100%(8/8)降低到10%(1/10)。我们将恢复基线呼吸状态的平均时间从224.1小时减少到33.8小时(9.3d减少到1.4 d)。干预后心肺指数评分略有增加(1到1.2),疼痛评分保持不变。结论:采用深度镇静指南和无创通气的多学科团队方法可以安全地减少激光光凝术中插管的需要,并更快地恢复到基线呼吸状态。
{"title":"Reducing Intubations and Related Risks in Neonates with Retinopathy of Prematurity Undergoing Laser Photocoagulation.","authors":"Vilmaris Quinones Cardona, Emma McNell Byrne, Novisi Arthur, Megan Young, Diane Lavery, Amanda Carroll, Swosti Joshi, Folasade Kehinde, Ogechukwu Menkiti","doi":"10.1097/pq9.0000000000000780","DOIUrl":"10.1097/pq9.0000000000000780","url":null,"abstract":"<p><strong>Introduction: </strong>Although associated with respiratory morbidity, elective endotracheal intubation (ETI) for laser photocoagulation for retinopathy of prematurity (ROP) is the standard practice at our institution, with 100% of patients undergoing preoperation ETI. To mitigate this risk, we strove to reduce the percentage of infants intubated for laser photocoagulation by 30% by June 2022.</p><p><strong>Methods: </strong>We assembled a multidisciplinary team and implemented a deep sedation guideline utilizing dexmedetomidine, fentanyl, and midazolam with noninvasive ventilation support for laser photocoagulation in January 2020. Outcome, process, and balancing measures tracked the efficacy and safety of the quality improvement project.</p><p><strong>Results: </strong>We reduced the percentage of infants requiring intubation for laser photocoagulation from 100% (8/8) to 10% (1/10). We reduced the average time to return to baseline respiratory status from 224.1 to 33.8 hours (9.3d to1.4 d). Cardiorespiratory index scores slightly increased (1 to 1.2), and pain scores remained unchanged after interventions.</p><p><strong>Conclusions: </strong>A multidisciplinary team approach using a deep sedation guideline and noninvasive ventilation can safely reduce the requirement for intubation during laser photocoagulation with a faster return to baseline respiratory status.</p>","PeriodicalId":74412,"journal":{"name":"Pediatric quality & safety","volume":"10 1","pages":"e780"},"PeriodicalIF":1.2,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11671073/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142904371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increasing Premedication for Neonatal Intubation: A Quality Improvement Initiative. 增加新生儿插管前用药:质量改进倡议。
IF 1.2 Q3 PEDIATRICS Pub Date : 2024-12-24 eCollection Date: 2025-01-01 DOI: 10.1097/pq9.0000000000000778
Michelle H Lucena, Toshiba Morgan-Joseph, Alecia Thompson-Branch

Introduction: Endotracheal intubation is frequent in the neonatal intensive care unit (NICU) but may result in neonatal distress and instability. Premedication reduces adverse effects, such as hypoxia, bradycardia, and pain. The Specific, Measurable, Achievable, Relevant and Time-Bound aim for this project was to increase premedication use for nonemergent neonatal intubation in a specific NICU from 22% to 80% from March 2021 to May 2023.

Methods: We use quality improvement methodology to explain our theory for improvement. Our key driver diagram depicts this initiative's aims, key drivers, and interventions to increase premedication use for neonatal intubation. We defined exclusion criteria and medications, and one author collected demographic data retrospectively after the procedure. The stakeholders summarized the baseline data, performed plan-do-study-act cycles, and showed outcome measures in a statistical process control chart. Statistical analysis used Fisher's exact test to compare categorical variables.

Results: Between 2021 and 2023, 333 infants underwent endotracheal intubation; 130 infants were included. The most common indication for intubation was hypoxemic respiratory failure-52% (68/130). Premedication use increased from 22% to 52%. Among the exclusion criteria, the most common indication for nonpremedication was intubation in the delivery room, 38.4% (78/203). In the premedication group, intubation on the first attempt occurred in 77.6% (52/67) of the cases, versus the nonpremedication group, 66.7% (32/48) (P = 0.3).

Conclusions: Premedication for neonatal intubation increased by 30%, although we did not reach the desired 80% goal. Establishing a premedication bundle, alongside a unit-specific protocol and effective teamwork, marks the initial stride toward enhancing analgesia/sedation practices in the NICU.

气管插管在新生儿重症监护病房(NICU)是常见的,但可能导致新生儿窘迫和不稳定。预用药可减少不良反应,如缺氧、心动过缓和疼痛。该项目的具体、可测量、可实现、相关和有时限的目标是在2021年3月至2023年5月期间,将特定NICU非急诊新生儿插管的药物前使用率从22%提高到80%。方法:我们使用质量改进方法论来解释我们的改进理论。我们的关键驱动图描述了该倡议的目标、关键驱动因素和干预措施,以增加新生儿插管的药物前使用。我们定义了排除标准和药物,一位作者在手术后回顾性收集了人口统计学数据。利益相关者总结基线数据,执行计划-执行-研究-行动循环,并在统计过程控制图中显示结果度量。统计分析采用Fisher精确检验来比较分类变量。结果:在2021年至2023年期间,333名婴儿接受了气管插管;其中包括130名婴儿。最常见的插管指征是低氧性呼吸衰竭-52%(68/130)。药物前使用率从22%上升到52%。排除标准中,最常见的非药物前指征是产房插管,占38.4%(78/203)。用药前组首次插管率为77.6%(52/67),而非用药前组为66.7% (32/48)(P = 0.3)。结论:新生儿插管前用药增加了30%,尽管我们没有达到预期的80%的目标。在NICU建立用药前捆绑包,同时制定单位特定的方案和有效的团队合作,标志着在加强镇痛/镇静实践方面迈出了第一步。
{"title":"Increasing Premedication for Neonatal Intubation: A Quality Improvement Initiative.","authors":"Michelle H Lucena, Toshiba Morgan-Joseph, Alecia Thompson-Branch","doi":"10.1097/pq9.0000000000000778","DOIUrl":"10.1097/pq9.0000000000000778","url":null,"abstract":"<p><strong>Introduction: </strong>Endotracheal intubation is frequent in the neonatal intensive care unit (NICU) but may result in neonatal distress and instability. Premedication reduces adverse effects, such as hypoxia, bradycardia, and pain. The Specific, Measurable, Achievable, Relevant and Time-Bound aim for this project was to increase premedication use for nonemergent neonatal intubation in a specific NICU from 22% to 80% from March 2021 to May 2023.</p><p><strong>Methods: </strong>We use quality improvement methodology to explain our theory for improvement. Our key driver diagram depicts this initiative's aims, key drivers, and interventions to increase premedication use for neonatal intubation. We defined exclusion criteria and medications, and one author collected demographic data retrospectively after the procedure. The stakeholders summarized the baseline data, performed plan-do-study-act cycles, and showed outcome measures in a statistical process control chart. Statistical analysis used Fisher's exact test to compare categorical variables.</p><p><strong>Results: </strong>Between 2021 and 2023, 333 infants underwent endotracheal intubation; 130 infants were included. The most common indication for intubation was hypoxemic respiratory failure-52% (68/130). Premedication use increased from 22% to 52%. Among the exclusion criteria, the most common indication for nonpremedication was intubation in the delivery room, 38.4% (78/203). In the premedication group, intubation on the first attempt occurred in 77.6% (52/67) of the cases, versus the nonpremedication group, 66.7% (32/48) (<i>P</i> = 0.3).</p><p><strong>Conclusions: </strong>Premedication for neonatal intubation increased by 30%, although we did not reach the desired 80% goal. Establishing a premedication bundle, alongside a unit-specific protocol and effective teamwork, marks the initial stride toward enhancing analgesia/sedation practices in the NICU.</p>","PeriodicalId":74412,"journal":{"name":"Pediatric quality & safety","volume":"10 1","pages":"e778"},"PeriodicalIF":1.2,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11671087/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142904368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using Quality Improvement to Design and Evaluate an Outpatient Day Treatment Pathway for Pediatric Patients with Diabetes Mellitus Requiring Insulin Initiation. 利用质量改进设计和评估针对需要开始使用胰岛素的儿科糖尿病患者的门诊日间治疗路径。
IF 1.2 Q3 PEDIATRICS Pub Date : 2024-11-20 eCollection Date: 2024-11-01 DOI: 10.1097/pq9.0000000000000776
Svetlana Azova, Charumathi Baskaran, Sara Einis, Jennifer Fortin, Marisa Silva, Miriam Gorman, Benjamin Ethier, Sonal Nanavati, Olivia Sterns, Katharine Garvey, Erinn T Rhodes

Introduction: Education and management of children with new-onset or established diabetes mellitus (DM) requiring insulin initiation do not always require hospitalization. We developed a pathway for outpatient day treatment of select patients after initial evaluation in the emergency department (ED) at a pediatric, tertiary care academic medical center.

Methods: A multidisciplinary team identified key initial eligibility criteria for outpatient day treatment for insulin initiation, including absence of diabetic ketoacidosis, age ≥3 years, and plasma beta-hydroxybutyrate (BOHB) <1 mmol/L. Electronic medical record reviews and surveys administered to endocrine providers determined exclusions or reasons for nonparticipation. Refinement of the pathway occurred through iterative plan-do-study-act cycles. Statistical process control evaluated the uptake among eligible patients.

Results: We launched the pathway in September 2020. Of 534 patients presenting to the ED with new-onset or established DM requiring insulin initiation in the first 2.5 years, 198 were potentially eligible for day treatment. Of these, 65 children (33%) completed the pathway. One additional patient was hospitalized following Day 1 of education due to newly identified psychosocial stressors. The increase of BOHB cutoff to 1.5 mmol/L and the option of rapid-acting insulin bolus for borderline BOHB resulted in a significant shift in utilization from a mean of 24.4% to 41.1%. Persistent barriers to participation include limited appointment availability, weekend presentation, and patient/family concerns.

Conclusions: Outpatient day treatment was successful for select pediatric patients with new-onset or established DM requiring insulin initiation. However, this approach necessitates flexible resources and supportive patient messaging.

导言:对于需要使用胰岛素的新发或已确诊糖尿病(DM)患儿的教育和管理并不总是需要住院治疗。我们在一家儿科三级医疗学术中心的急诊科(ED)进行初步评估后,为部分患者制定了日间门诊治疗方案:多学科团队确定了胰岛素日间门诊治疗的主要初始资格标准,包括无糖尿病酮症酸中毒、年龄≥3 岁和β-羟丁酸(BOHB)血浆:我们于 2020 年 9 月启动了该路径。在急诊室就诊的 534 名新发或已确诊的糖尿病患者中,有 198 人在 2.5 年内需要开始使用胰岛素,其中 65 名儿童(33%)可能符合日间治疗的条件。其中 65 名儿童(33%)完成了日间治疗。另有一名患者因新发现的社会心理压力而在教育第一天后住院治疗。将 BOHB 临界值提高到 1.5 mmol/L,并为 BOHB 临界值的患者提供速效胰岛素栓,使得使用率从平均 24.4% 显著提高到 41.1%。持续存在的参与障碍包括预约时间有限、周末就诊以及患者/家属的顾虑:日间门诊治疗对于某些需要开始使用胰岛素的新发或已确诊糖尿病儿科患者来说是成功的。然而,这种方法需要灵活的资源和支持性的患者信息。
{"title":"Using Quality Improvement to Design and Evaluate an Outpatient Day Treatment Pathway for Pediatric Patients with Diabetes Mellitus Requiring Insulin Initiation.","authors":"Svetlana Azova, Charumathi Baskaran, Sara Einis, Jennifer Fortin, Marisa Silva, Miriam Gorman, Benjamin Ethier, Sonal Nanavati, Olivia Sterns, Katharine Garvey, Erinn T Rhodes","doi":"10.1097/pq9.0000000000000776","DOIUrl":"10.1097/pq9.0000000000000776","url":null,"abstract":"<p><strong>Introduction: </strong>Education and management of children with new-onset or established diabetes mellitus (DM) requiring insulin initiation do not always require hospitalization. We developed a pathway for outpatient day treatment of select patients after initial evaluation in the emergency department (ED) at a pediatric, tertiary care academic medical center.</p><p><strong>Methods: </strong>A multidisciplinary team identified key initial eligibility criteria for outpatient day treatment for insulin initiation, including absence of diabetic ketoacidosis, age ≥3 years, and plasma beta-hydroxybutyrate (BOHB) <1 mmol/L. Electronic medical record reviews and surveys administered to endocrine providers determined exclusions or reasons for nonparticipation. Refinement of the pathway occurred through iterative plan-do-study-act cycles. Statistical process control evaluated the uptake among eligible patients.</p><p><strong>Results: </strong>We launched the pathway in September 2020. Of 534 patients presenting to the ED with new-onset or established DM requiring insulin initiation in the first 2.5 years, 198 were potentially eligible for day treatment. Of these, 65 children (33%) completed the pathway. One additional patient was hospitalized following Day 1 of education due to newly identified psychosocial stressors. The increase of BOHB cutoff to 1.5 mmol/L and the option of rapid-acting insulin bolus for borderline BOHB resulted in a significant shift in utilization from a mean of 24.4% to 41.1%. Persistent barriers to participation include limited appointment availability, weekend presentation, and patient/family concerns.</p><p><strong>Conclusions: </strong>Outpatient day treatment was successful for select pediatric patients with new-onset or established DM requiring insulin initiation. However, this approach necessitates flexible resources and supportive patient messaging.</p>","PeriodicalId":74412,"journal":{"name":"Pediatric quality & safety","volume":"9 6","pages":"e776"},"PeriodicalIF":1.2,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11578214/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142683714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation of a Neonatal Hyperbilirubinemia Clinical Pathway in a Pediatric Emergency Department. 在儿科急诊室实施新生儿高胆红素血症临床路径。
IF 1.2 Q3 PEDIATRICS Pub Date : 2024-11-20 eCollection Date: 2024-11-01 DOI: 10.1097/pq9.0000000000000774
Collin R Miller, Catherine Haut, Arezoo Zomorrodi, Karina Chara, Janice Wilson

Background: High volumes and competing priorities delay care initiation for neonatal hyperbilirubinemia within the pediatric emergency department (ED). Our freestanding children's hospital developed a quality improvement project to implement a nurse-initiated neonatal hyperbilirubinemia clinical pathway (CP) intended to decrease treatment initiation and intravenous fluid (IVF) rates.

Methods: A multidisciplinary team used the model for improvement to delineate and address key drivers of treatment delays. The team established a nurse-driven CP and enhanced the electronic health record to support and enforce new workflows, which included capillary specimen collection and phototherapy initiation before the first provider assessment. IVF criteria and laboratory evaluation were standardized. The primary aim was to decrease the time to initiation of phototherapy from a mean of 136 to 60 minutes after ED arrival for 6 months. The secondary aim was to decrease the proportion of patients obtaining IVF from 31% to 15% for the same time frame.

Results: ED arrival to phototherapy initiation decreased from 136 to 49 minutes. The IVF rate decreased from 31% to 12%. ED length of stay decreased from 185 to 122 minutes. Hospital length of stay remained unchanged.

Conclusions: A nurse-initiated CP for neonates with hyperbilirubinemia improved time-to-care initiation and ED throughput while decreasing unnecessary IVF administration.

背景:在儿科急诊室(ED)中,高流量和优先级竞争会延误新生儿高胆红素血症的治疗。我们的独立儿童医院开展了一项质量改进项目,实施由护士发起的新生儿高胆红素血症临床路径(CP),旨在降低治疗启动率和静脉输液(IVF)率:方法:一个多学科团队利用改进模型来确定并解决治疗延误的关键因素。该团队建立了以护士为主导的 CP,并增强了电子病历以支持和执行新的工作流程,其中包括在首次提供者评估之前收集毛细血管标本和启动光疗。试管婴儿标准和实验室评估均已标准化。主要目标是在 6 个月内将启动光疗的平均时间从到达急诊室后的 136 分钟缩短至 60 分钟。次要目标是将同期获得体外受精的患者比例从 31% 降至 15%:结果:从到达急诊室到开始光疗的时间从 136 分钟缩短至 49 分钟。体外受精率从 31% 降至 12%。急诊室停留时间从 185 分钟缩短至 122 分钟。住院时间保持不变:由护士发起的新生儿高胆红素血症光疗改善了护理启动时间和急诊室吞吐量,同时减少了不必要的静脉输液。
{"title":"Implementation of a Neonatal Hyperbilirubinemia Clinical Pathway in a Pediatric Emergency Department.","authors":"Collin R Miller, Catherine Haut, Arezoo Zomorrodi, Karina Chara, Janice Wilson","doi":"10.1097/pq9.0000000000000774","DOIUrl":"10.1097/pq9.0000000000000774","url":null,"abstract":"<p><strong>Background: </strong>High volumes and competing priorities delay care initiation for neonatal hyperbilirubinemia within the pediatric emergency department (ED). Our freestanding children's hospital developed a quality improvement project to implement a nurse-initiated neonatal hyperbilirubinemia clinical pathway (CP) intended to decrease treatment initiation and intravenous fluid (IVF) rates.</p><p><strong>Methods: </strong>A multidisciplinary team used the model for improvement to delineate and address key drivers of treatment delays. The team established a nurse-driven CP and enhanced the electronic health record to support and enforce new workflows, which included capillary specimen collection and phototherapy initiation before the first provider assessment. IVF criteria and laboratory evaluation were standardized. The primary aim was to decrease the time to initiation of phototherapy from a mean of 136 to 60 minutes after ED arrival for 6 months. The secondary aim was to decrease the proportion of patients obtaining IVF from 31% to 15% for the same time frame.</p><p><strong>Results: </strong>ED arrival to phototherapy initiation decreased from 136 to 49 minutes. The IVF rate decreased from 31% to 12%. ED length of stay decreased from 185 to 122 minutes. Hospital length of stay remained unchanged.</p><p><strong>Conclusions: </strong>A nurse-initiated CP for neonates with hyperbilirubinemia improved time-to-care initiation and ED throughput while decreasing unnecessary IVF administration.</p>","PeriodicalId":74412,"journal":{"name":"Pediatric quality & safety","volume":"9 6","pages":"e774"},"PeriodicalIF":1.2,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11578199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142683711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pediatric quality & safety
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1